Napatree Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$425K Sell
28,515
-1,339
-4% -$20.6K 0.24% 115
2024
Q4
$445K Buy
+29,854
New +$487K 0.26% 103

Other funds holding OGN

Napatree Capital's OGN Position: Q1 2025 in Review

Napatree Capital reduced its Organon & Co (OGN) stake by 4.5% in Q1 2025, selling an estimated $20.6K and leaving 28,515 shares worth $425K. The position accounts for 0.24% of the portfolio, ranked #115.

Napatree Capital first reported a position in OGN in Q4 2024 and has held it in 2 quarters since. The position peaked at $445K in Q4 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Napatree Capital held 28,515 shares of Organon & Co worth $425K as of Q1 2025.
  • Napatree Capital sold 1,339 Organon & Co shares in Q1 2025, an estimated $20.6K.
  • Organon & Co made up 0.24% of Napatree Capital's portfolio in Q1 2025, its #115 holding.
  • Napatree Capital first reported a position in Organon & Co in Q4 2024 and has held it in 2 quarters since.
  • Napatree Capital's Organon & Co position peaked at $445K in Q4 2024.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.